Exact Sciences (EXAS) Tops Q3 EPS by 10c, FY Revenue Guidance Misses at Mid-Point
Tweet Send to a Friend
Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.31), $0.10 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
